Necrotizing Enterocolitis: Pathophysiology, Management, and Clinical Considerations
Pathophysiology
NEC develops at the intersection of intestinal immaturity, gut microbiota dysbiosis, impaired mucosal immunity, and suboptimal feeding practices in preterm infants 1. The disease represents a spectrum of inflammatory disorders driven by systemic inflammation, microbiota dysregulation, and intestinal hypoxic injury 2. Preterm infants exhibit altered microbial colonization patterns during the first weeks to months of life, with frequent clinical interventions (antibiotics, delayed enteral feeds, stress-inducing procedures) collaterally modifying the gut microbiome and increasing vulnerability to NEC 3.
The microbiota composition differs significantly in infants with NEC compared to healthy infants, providing the rationale for microbiota-oriented treatments 4. This period of delayed and altered microbial colonization, though relatively short, has far-reaching consequences on homeostatic signaling mechanisms 3.
Prevention Strategies
Probiotic Prophylaxis
For preterm infants (<37 weeks gestational age) with low birth weight, use combination probiotics containing Lactobacillus and Bifidobacterium species to prevent NEC 4. The AGA guideline demonstrates that these combinations reduce:
- All-cause mortality (OR 0.56,95% CI 0.39-0.80)
- Severe NEC stage II or greater (OR 0.35,95% CI 0.20-0.59)
Effective single-strain options include:
- B. animalis subsp lactis DSM 15954 (OR 0.31,95% CI 0.13-0.74)
- L. reuteri DSM 17938 or ATCC 55730 (OR 0.55,95% CI 0.34-0.91)
- L. rhamnosus ATCC 53103 (OR 0.44,95% CI 0.21-0.90)
All supported by moderate to high-quality evidence 4.
Nutritional Interventions
Promote exclusive human milk feeding as the primary preventive measure 5. Formula feeding versus breast milk represents a critical risk factor in NEC pathogenesis 1. Use cautious antibiotic stewardship to minimize microbiome disruption 1.
Diagnosis
NEC diagnosis remains challenging due to subtle presentation, often beginning with feeding intolerance 6. The disease relies on clinical and radiographic findings, with no single fully reliable biomarker 2. However, CBC parameters show promise for early detection and risk stratification, particularly when integrated with clinical and radiologic data 2.
Key clinical features to monitor:
- Feeding intolerance (early sign)
- Abdominal distension
- Bloody stools
- Hemodynamic instability
- Pneumatosis intestinalis on imaging
- Pneumoperitoneum (surgical emergency)
Medical Management
Initial Treatment
Implement immediate bowel rest and careful antibiotic therapy upon diagnosis 6. The mainstay of early-stage treatment remains largely supportive 5.
Critical pitfall: Extended periods of bowel rest and prolonged antibiotic courses following NEC diagnosis can further disrupt the microbiome 7. Balance infection control with minimizing unnecessary antibiotic exposure.
Post-NEC Nutritional Rehabilitation
Initiate enteral nutrition early after NEC resolution 8. Limited available data suggest that achieving early enteral nutrition is not associated with worse short-term outcomes and may reduce:
- Parenteral nutrition dependence
- Liver dysfunction (demonstrated in three studies implementing standardized feeding regimes) 8
- Feed-related complications
Recognize patient characteristics predicting nutritional tolerance, minimize bowel rest periods, and standardize dietary practices 7. Early introduction of enteral feeds does not increase NEC recurrence 8.
Surgical Management
Indications for Surgery
Operate when pneumoperitoneum and intestinal perforation occur 6. The 2025 ERNICA guideline provides evidence-based recommendations on surgical timing, though certainty of evidence remains low for most recommendations 9.
Surgical Approach
The panel developed seven recommendations covering:
- Peritoneal drainage versus laparotomy decision-making
- Surgical technique selection
- Management of extensive NEC
- Post-operative enteral feeding strategies 9
Mortality rates for surgical NEC range from 20-30%, particularly affecting infants with birthweight <1,500g 9, 6.
Outcomes and Long-term Considerations
Common long-term sequelae include:
- Short bowel syndrome
- Impaired neurodevelopment 4
- Prolonged parenteral nutrition requirements
- Need for intestinal rehabilitation 5
The ERNICA guideline addresses neurodevelopmental outcomes as a critical consideration in surgical decision-making 9.
Clinical Pitfalls to Avoid
Delayed recognition: NEC presents with slow, insidious onset. Maintain high suspicion in at-risk preterm infants with feeding intolerance 6.
Excessive bowel rest: While necessary initially, prolonged bowel rest post-NEC increases complications. Transition to enteral feeds based on patient tolerance, not arbitrary timelines 7, 8.
Antibiotic overuse: Balance infection treatment with microbiome preservation. Minimize duration when clinically appropriate 1, 7.
Formula feeding in high-risk infants: Prioritize human milk whenever possible as a primary prevention strategy 1, 5.
Inconsistent probiotic use: Despite strong evidence, implementation varies. Use specific strains with demonstrated efficacy in your population 4, 3.